Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

VFC's Stock House: Immunocellular Therapeutics May Be Immune To A Broad Market Downturn

(EMAILWIRE.COM, April 10, 2012 ) New York, NY -- With a new trading quarter upon us, the broad markets as a whole look ready to take a downswing after a strong first quarter and months of running higher as the global economy demonstrated a strength and resiliency not seen for years. Although a downswing - or "correction", as some might term it - could be in the works, there are some companies and stocks out there with enough pending news, catalysts and developments that may allow them to weather the storm and outperform the near-term market trends.



Immunocellular Therapeutics (IMUC) is one that has already well-outperformed the market this year and could maintain strength into any general downswing.



Over the course of the past six months Immunocellular has emerged from one of a quite few speculative Phase II cancer immunotherapy companies to become a potential front-runner in the next generation of such treatments.



Fueled by encouraging survival data from early trials and positive developments on the business front, IMUC has soared past the two dollar mark with ease and even breached the three dollar barrier for a period, a level that the share price still flirts with on a near-daily basis, even as the market as a whole is on a breather.



Other developments and pending catalysts also bode well for both the short and long term future of Immunocellular.



For full report visit: http://vfcsstockhouse.com/blog/article/-immunocellular-therapeutics-may-be-immune-to-a-broad-market-downturn



For this week's list of stocks to watch visit: http://vfcsstockhouse.com/blog/article/-weekly-stock-watch-april-9-13-ampe-pbth-imuc-nby-nriff-cndo-siga-imsc-yhoo-fb-siri-cvm-aapl-sbux-mcd-agen



For Tuesday's stock market roundup visit: http://vfcsstockhouse.com/blog/article/-tuesday-morning-roundup-facebook-yhoo-aol-msft-imsc-ctso-cpst-sppi-amrn-cldx-ampe



About VFCsStockHouse.com:



VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFCs Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.



Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse



'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213



For full disclaimer visit: http://vfcsstockhouse.com



VFC's Stock House
VFC
240-786-2111
vfc@vfcsstockhouse.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.


Wall St. little changed at open after two-day run
19 Dec 2014 at 6:33am

NEW YORK (Reuters) - U.S. stocks opened little changed on Friday, after the Federal Reserve's most recent policy statement sparked the best two-day run for the benchmark S&P 500 in three years.


European regulators recommend approval of Orexigen's obesity pill
19 Dec 2014 at 5:24am
(Reuters) - European regulators recommended the approval of Orexigen Therapeutics Inc's diet pill, which could become the first prescription medicine for obesity to be approved in the European Union in nearly a decade. The drug, sold as Contrave by partner Takeda Pharmaceutical Co in the United States, will be marketed as Mysimba in Europe. The European Commission is expected to give its decision on the drug in early 2015, Orexigen said. The treatment, which won U.S. ...

Novo Nordisk gets positive opinion on Tresiba for children in Europe
19 Dec 2014 at 5:12am
COPENHAGEN (Reuters) - Drug maker Novo Nordisk said the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the use of its diabetes drug Tresiba for the treatment of children and adolescents. An European Commission approval of the label expansion means physicians in the European Union will be able to prescribe Tresiba to children with type 1 and type 2 diabetes, Denmark's Novo Nordisk said in a statement on Friday. ...

Europe recommends approval for first stem-cell therapy
19 Dec 2014 at 5:08am
LONDON (Reuters) - European regulators have recommended approval of the first medicine containing stem cells to treat a rare condition caused by burns to the eye. The European Medicines Agency said on Friday that Holoclar, from privately held Italian company Chiesi, had been given a green light for moderate to severe limbal stem cell deficiency due to physical or chemical burns. Left untreated, the condition can result in blindness. Holoclar is a living tissue product made from a biopsy taken from a small undamaged area of the patient?s cornea and grown in the laboratory using cell culture. ...

Philippine health minister resigns over vaccine purchase
19 Dec 2014 at 5:01am
MANILA (Reuters) - Philippine President Benigno Aquino has accepted the resignation of his health minister over the purchase of pneumonia vaccines in 2012 which government investigators later questioned, a spokesman said on Friday. Health Secretary Enrique Ona, who has been on leave since October, submitted his letter of resignation on Thursday even before the completion of a government inquiry into four deals at his ministry. "The President has accepted his resignation effective today," Herminio Coloma, the president's press secretary, told reporters in a text message. ...


Double blow for Roche as breast cancer, Alzheimer's studies fail
19 Dec 2014 at 4:58am

By Silke Koltrowitz and Ben Hirschler ZURICH/LONDON (Reuters) - Roche suffered a double blow on Friday as two clinical studies of drugs for breast cancer and Alzheimer's disease failed, sparking the biggest percentage fall in its stock in five years. The Swiss drugmaker said it was ending a late-stage study of experimental Alzheimer's drug gantenerumab after it failed to prove effective, underlining the difficulty of treating the memory-robbing disease and removing "blue sky" upside for the shares. ...


Orexigen diet pill recommended for approval in Europe
19 Dec 2014 at 4:49am
LONDON (Reuters) - A new diet pill from Orexigen Therapeutics Inc has been recommended for approval in Europe, the European Medicines Agency (EMA) said on Friday. The drug, known as Contrave in the United States, will be marketed as Mysimba in Europe. The medicine won U.S. approval in September and is a combination of the antidepressant bupropion and Orexigen's formulation of naltrexone, designed to prevent drug dependence. ...

School Takes Away Blind Boy's Cane as Punishment for Acting Up
19 Dec 2014 at 4:19am
A school took away an 8-year-old blind boy's cane as punishment for acting up and replaced it with a pool noodle, his father told ABC News.


Alstom shareholders back 12.35 billion euro sale of power arm to GE
19 Dec 2014 at 4:06am

PARIS (Reuters) - Alstom shareholders on Friday backed with 99.2 percent of votes the French engineering group's plan to sell most of its power equipment business to General Electric and refocus on its smaller rail arm.


U.S. environment agency set to issue long-anticipated rules for coal ash disp...
19 Dec 2014 at 4:03am
By Jonathan Kaminsky (Reuters) - The U.S. Environmental Protection Agency is due to issue long-anticipated regulations on Friday for the disposal of coal ash, a byproduct of coal-based power production that contains toxic materials such as arsenic and lead. The agency, which agreed to the Friday deadline to settle a lawsuit filed by environmental groups, first proposed rules governing coal ash storage in 2010. That was in the wake of a massive spill at a ruptured holding pond in Tennessee that has cost more than $1 billion to clean up. ...


Harmful road traffic noise affects a quarter of Europeans: study
19 Dec 2014 at 3:59am

OSLO (Reuters) - Harmful levels of road traffic noise affect one in four people in Europe and raise health risks ranging from sleepless nights to heart disease, the European Environment Agency said on Friday. In a first EEA assessment of the impact of noise pollution in Europe, it said the din undermines the ability of children to concentrate in some schools and disrupts nature, for instance by drowning out the songs birds use to attract mates. ...



Mozambique legalises abortion to stem maternal deaths
19 Dec 2014 at 3:51am

Mozambique has legalised abortion, making it one of the few countries in Africa to allow women to terminate unwanted pregnancies. President Armando Guebuza on Thursday quietly signed into law a revised penal code bill that eases prohibitions in abortion regulations, a move hailed by health groups. In Mozambique, the earlier law outlawing abortion, except in cases where the mother?s life or health is endangered, dates to the late 19th century, when the mainly Catholic Portuguese controlled the country. The other major creed in Mozambique is Islam, a faith which also does not support abortion.


How GE changed tack on Russia
19 Dec 2014 at 3:44am
By Tom Bergin LONDON (Reuters) - About five years ago, General Electric Co, the largest Western player in Russia's market for medical equipment, uncovered pervasive corruption in its Russian business. Ferdinando Beccalli-Falco, then chief executive of GE Germany and Developed Markets, told an investor conference in 2012 that senior management became aware of the problems around 2009. "We had to eliminate more than half of our healthcare organization because we discovered that they were happily scamming our customers, scamming against us and scamming against the government," Beccalli-Falco told the conference. A GE spokesman said Beccalli-Falco did not wish to comment, and the company declined to comment on its Russian business.


Special Report: Opaque middlemen exact high price in Russia's deals with the ...
19 Dec 2014 at 3:44am

By Tom Bergin and Stephen Grey MOSCOW/LONDON, Dec 19 (Reuters) - Russia pays hugely inflated prices for vital medical equipment made by Western companies, in part because some manufacturers channel sales through obscure intermediary companies, a Reuters examination has found. These middlemen firms, which have no easily traceable owners or offices, add mark-ups that mean Russian state hospitals frequently pay two or three times more than hospitals in the West for the same equipment. A Reuters examination of Russian customs data and state procurement records shows the price differences can be hundreds of thousands of dollars on a single item. An analysis of 20,000 transactions dated between January 2006 and July 2013 found that international companies sold Russia medical devices worth more than $2.8 billion through more than 150 obscure companies and partnerships.



U.N. chief, visiting Ebola countries, urges respect for health rules
19 Dec 2014 at 3:39am

By Matthew Mpoke Bigg MONROVIA (Reuters) - U.N. Secretary General Ban Ki-moon, starting a visit to Ebola-hit countries in West Africa, urged local communities to strictly follow health regulations in the face of signs that traditional funerals are still spreading the disease. Ban arrived in Liberia on Friday at the start of a two-day tour of four nations struck by the worst ever outbreak of the deadly haemorrhagic fever, including Sierra Leone, Guinea and Mali. ...


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC